Streetbeat News

Partnerships

EVAX

MRK

Evaxion Biotech A/S has successfully completed the initial phases of its vaccine collaboration with MSD, a tradename of Merck & Co., Inc. This partnership leverages the unique capabilities and know-how of both companies in vaccine development.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:32 pm

FANH

Fanhua Inc. has signed a supplementary agreement to its strategic framework deal with White Group, alongside announcing board changes. This move strengthens Fanhua's position as a leading financial services provider in China.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:27 pm

ZCAR

Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares dropped over 7% in premarket trading after announcing a partnership with SPARKCARS to add over 1,000 electric vehicles to its platform in India. Despite a 19% decrease in net revenue to $2.4 million in the third quarter, Zoomcar projects a significant revenue increase for the calendar year ending December 31, 2024, and expects to achieve a positive adjusted EBITDA run rate.

Portfolio Pulse from Nabaparna Bhattacharya

February 20, 2024 | 12:27 pm

PUYI

Puyi Inc., a third-party wealth management services provider in China, has signed a supplementary agreement with Singapore's White Group to enhance their strategic partnership. This development follows the initial framework agreement announced on February 2, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:26 pm

CMND

SPRC

Clearmind Medicine Inc. has submitted three international patent applications for psychedelic-based compounds, in collaboration with SciSparc Ltd., under the Patent Cooperation Treaty. These efforts are part of their ongoing partnership to develop therapies for central nervous system disorders.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:17 pm

COTY

Coty Inc. (NYSE:COTY) has signed a new agreement with Italian luxury fashion house Etro to produce and distribute Etro's fragrance lines and home scent collections beyond 2040. This deal emphasizes Coty's strategy to focus on fashion-driven licenses with significant multi-category potential. The partnership aims to explore new categories and innovations to expand Etro's beauty portfolio. Earlier, Coty also secured a long-term agreement with Marni, showcasing its strong alliances within the fashion industry.

Portfolio Pulse from Nabaparna Bhattacharya

February 20, 2024 | 12:14 pm

EVGN

Syngenta Crop Protection and Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN), have announced a partnership to discover and develop novel bio-insecticide solutions. The collaboration aims to combine Lavie Bio's technology platform with Syngenta's global R&D and commercialization capabilities.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:14 pm

DTIL

Precision BioSciences, Inc. (DTIL) has granted Caribou Biosciences a non-exclusive, worldwide license to use one of Precision's cell therapy patent families with CRISPR for human therapeutics. Financial terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:08 pm

ADC

AYX

HWBK

LRMR

Insider purchases in Hawthorn Bancshares, Alteryx, Larimar Therapeutics, and Agree Realty indicate confidence in these companies' prospects. Hawthorn Bancshares reported a Q4 loss, Alteryx expanded its partnership with Databricks, Larimar Therapeutics closed a public offering, and Agree Realty posted strong Q4 sales.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 11:53 am

IBM

WIT

Wipro has introduced an enterprise AI-ready platform, utilizing IBM Watsonx, aimed at accelerating the adoption of generative AI in enterprises. This initiative is part of a broader partnership between IBM and Wipro, which includes the creation of a tech hub to assist joint clients with AI integration.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 11:48 am